University Hospitals Seidman Cancer Center Offers a Full Range of Treatment Options for Esthesioneuroblastoma
The expert team at UH Seidman Cancer Center working closely with specialists from University Hospitals Neurological Institute's Brain Tumor and Neuro-Oncology Center is dedicated to diagnosing, treating and researching esthesioneuroblastoma, or olfactory neuroblastoma. Our team delivers a full range of cancer treatment options, from conventional methods to leading-edge alternatives for this rare sinus cavity cancer. UH Seidman Cancer Center is part of the National Cancer Institute-designated Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine and is one of an elite group of 41 comprehensive cancer hospitals nationwide.
Through our commitment to patient-centered care, we compassionately guide our patients with esthesioneuroblastoma through the treatment process, ensuring that they are fully educated every step of the way. Our personalized medical services are designed to satisfy the whole person, meeting each patient’s unique physical and emotional needs.
Leading Procedures and Therapies
Our entire multidisciplinary team evaluates and reviews every single case so leading procedures and combination therapies are based on the knowledge of our team of experts. Together, we work through every step of cancer care, seeking the latest medical advancements to offer patients a cure. Our leading-edge treatment options include:
Multiple Specialists Work as a Team
At UH Seidman Cancer Center, our patients benefit from a team approach to treating esthesioneuroblastoma. Our patients see multiple specialists who work together to create the most comprehensive, individualized cancer care plan possible. The following specialists may be involved in the care of esthesioneuroblastoma patients:
- Genetic counselors
- Medical geneticists
- Medical oncologists
- Nurse navigators
- Nurse practitioners
- Radiation oncologists
- Social workers
- Surgical oncologists
National Cancer Experts Guide Care Decisions
Our multidisciplinary cancer team meets weekly for a disease-specific tumor board review. Tumor board review involves a meeting where every single patient’s case is read and discussed among a team of national experts to guide the cancer care treatment plan. This review process ensures that all realistic treatment options for brain stem cancer are considered.
Cancer Clinical Trials
UH Seidman Cancer Center has many available clinical trials for patients with cancer. Patients participating in clinical trials may have the opportunity to be among the first to receive new therapies not yet available at other cancer treatment centers.